Stay updated on Pembrolizumab in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Lymphoma Clinical Trial page.

Latest updates to the Pembrolizumab in Lymphoma Clinical Trial page
- Check5 days agoChange DetectedAdded the MeSH term Malignant lymphoma, large B-cell, diffuse to the study indexing terms.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check26 days agoChange DetectedPage revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page shows Revision: v3.4.2; the earlier funding-status notice (Revision: v3.4.1) has been removed.SummaryDifference0.4%

- Check62 days agoChange DetectedAdditions include a site-wide funding/operational status notice (NIH Clinical Center is open) and a new Revision: v3.4.1; a prior Revision: v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check69 days agoChange DetectedAdded UI/text elements: 'Show glossary', 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and a new revision label 'Revision: v3.4.0'. Removed or renamed older labels: 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Lymphoma Clinical Trial page.